ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO2538

Exposure to Tacrolimus Trough Levels Below 6 ng/mL During the First Year Is Associated with Inferior Kidney Graft Survival

Session Information

Category: Transplantation

  • 1902 Transplantation: Clinical

Authors

  • Agur, Timna, Department of Nephrology and Hypertension, Rabin Medical Center Israel, Petah Tikva, Israel
  • Rahamimov, Ruth, Department of Nephrology and Hypertension, Rabin Medical Center Israel, Petah Tikva, Israel
  • Rozen-zvi, Benaya, Department of Nephrology and Hypertension, Rabin Medical Center Israel, Petah Tikva, Israel
Background

Accumulating data indicates that sub-therapeutic levels of calcineurin inhibitors are associated with long-term graft loss. However, while tacrolimus (TAC) was shown to provide adequate immunosuppression with lower acute rejection rate, its optimal maintenance dose for long term graft survival is still unknown. The aim of our study was to determine the minimal TAC trough level, which is associated with improved kidney graft survival.

Methods

We conducted a retrospective cohort study based on the RMC registry. We defined five TAC trough level intervals: 3-4, 4-5, 5-6, 6-7, and 7-8ng/ml. We calculated the exposure time for each drug level interval during the first year following transplantation, defined as the cumulative number of days at each interval. This measure was adjusted to the exposure time below a given interval-level, allowing us to define the threshold for optimal TAC trough level as the upper limit of the interval. We then determined the association between the adjusted exposure time at each TAC level-interval and our primary outcome, death-censored graft survival.

Results

We included 1417 patients with a median follow up of 5.3 years (IQR 2.9-8.5 years). TAC through level interval of 5-6ng/ml was the highest interval which demonstrated a statistically significant association between exposure time and increased risk of graft loss, even after adjustment to the exposure time below 5ng/ml (HR 1.58 per log days, p<0.001). These results remained consistent in an extensive multivariate analysis (HR 1.44, p<0.004) and were not significantly changed when we analyzed for death-included graft survival (HR 1.2, p<0.026) or the first three months and the subsequent nine months separately (HR 1.93, p<0.001, HR 1.56, p<0.001 respectively). Cumulative exposure time above 14 days to TAC trough level< 6ng/ml, was significantly associated with increased risk of graft loss in most studied subgroups including age, gender, low and high immunologic risk recipients, except for the subgroup of recipients with diabetes.

Conclusion

Prolonged exposure time to TAC trough level between 5-6ng/ml within the first-year post-transplant was independently associated with increased risk of long-term graft loss. These results imply that keeping TAC trough levels above 6ng/ml during the first year might improve kidney transplantation outcomes.